About this trial
Objective: To explore the effect of etomidate and esketamine on postoperative pain after tonsillectomy in children.
Methods: Investigators enrolled 64 children with American Society of Anesthesiologists (ASA) physical status I and II, aged 2-10 years, and scheduled for elective undergoing tonsillectomy with general anesthesia. All the enrolled patients were randomly divided into etomidate and fentanyl group (Group A) and etomidate and esketamine group (Group B). In the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively; in the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation. Anesthesiologists who were unaware of the grouping recorded the FlACC Pain Scale at 2 h, 8 h, and 24 h after surgery.
Eligibility criteria
Qualifiers
Children who underwent elective tonsillectomy
Aged 2-10 years old
ASA class I-II
Disqualifiers
Children with hepatic or renal dysfunction
Those with increased intracranial or intra-ocular pressure
Children with schizophrenia, bipolar disorder, and any other psychiatric condition
Children with preexisting chronic pain
Trial design
Treatments tested in this trial
- Etomidate and fentanyl group
- Etomidate and esketamine group